Chinese Haematology Specialist Lu Daopei Medical Raises ￥500M in Series B

According to PEdaily.cn, Lu Daopei Medical, a Chinese haematology specialist medical group, has raised over 500 million yuan in a Series B funding round led by Temasek Holdings, with participation from Bahrain-based alternative investment firm Investcorp.

Lu Daopei Medical was founded in 2001 by Lu Daopei, an expert of haematology. After nearly 20 years of development, now the group has a blood disease hospital in Henan, two hospitals in Beijing and a blood disease hospital in Shanghai, becoming China's leading private medical group in haematology field. 

At present, Lu Daopei Medical has become one of the world's most active hematopoietic stem cell transplant centers. In 2019, 1081 hematopoietic stem cell transplants were successfully completed, making it the largest transplant center in China recently. 70% of them were semi-compatible transplants, which greatly improved the chances of blood tumor patients finding a donor, enabling the majority of patients to be treated.

As a leader in the field of blood diseases, Lu Daopei Medical is actively trying new treatments. Lu Daopei Medical was one of the earliest centers to conduct clinical trials of CAR-T for leukemia in 2015. By cooperating with outstanding CAR-T cell manufacturers in China, the group has accumulated a lot of experience in the field of CAR-T cell therapy and developed the characteristic transplant with CAR-T cells as the bridge. 

Hazem Ben-Gacem, CEO of Investcorp, said, "Investcorp is pleased to invest in Lu Daopei Medical, a leading medical group of blood diseases in China. We highly respect the vision of the management team and look forward to closing cooperation in the future, to help Lu Daopei Medical expand the capacity of patients and consolidate its world-leading position, to benefit millions of patients with blood diseases."

Incorporated in 1974, Temasek is an investment company based in Singapore. Temasek's portfolio covers a broad spectrum of sectors: telecommunications, media & technology; financial services; transportation & industrials; consumer & real estate; life sciences & agriculture; energy & resources. 

Founded in 1982, Investcorp is a leading global manager of alternative investments with six lines of businesses, including private equity, real estate, absolute return investments, infrastructure, credit management, and strategic capital.